Published on 2026-01-27T14:00:58.000Z, a new clinical trial has been announced comparing the routine use of the ActiValve to standard voice prostheses in patients who have undergone laryngectomy. The trial, sponsored by M.D. Anderson Cancer Center, aims to evaluate the safety and efficacy of the ActiValve device.
In this article: Introduction | What changed? | Who is affected? | FAQ | Conclusion | Disclaimer | Announcement Line
What is the ActiValve and how does it work?
The ActiValve is a medical device designed to improve voice quality in patients who have undergone laryngectomy. It is manufactured by Atos Medical and is intended to be used in conjunction with a voice prosthesis. The device is designed to reduce the risk of complications associated with voice prostheses, such as leakage and blockage.
What are the implications of this clinical trial?
The clinical trial comparing the ActiValve to standard voice prostheses is significant because it may provide evidence of the safety and efficacy of the ActiValve device. If the trial shows that the ActiValve is effective in reducing complications and improving voice quality, it could lead to a change in the standard of care for patients who have undergone laryngectomy.
How will the trial be conducted?
The trial will be conducted at M.D. Anderson Cancer Center and will involve patients who have undergone laryngectomy. Patients will be randomly assigned to receive either the ActiValve or a standard voice prosthesis. The trial will evaluate the safety and efficacy of the ActiValve device and compare it to the standard voice prosthesis.
Who is eligible to participate in the trial?
Patient eligibility criteria include having undergone laryngectomy and being a candidate for a voice prosthesis. Patients who are interested in participating in the trial should contact the study sponsor or principal investigator for more information.
Frequently Asked Questions
1. What is the purpose of the clinical trial?
2. How will the trial be conducted?
3. Who is eligible to participate in the trial?
4. What are the potential benefits and risks of participating in the trial?
5. How can I get more information about the trial?
Conclusion
In conclusion, the clinical trial comparing the ActiValve to standard voice prostheses is an important study that may provide evidence of the safety and efficacy of the ActiValve device. Patients who have undergone laryngectomy and are interested in participating in the trial should contact the study sponsor or principal investigator for more information.
Disclaimer
This article is not intended to provide medical advice. It is intended to provide general information about a clinical trial. Patients should consult with their healthcare provider before making any decisions about participating in a clinical trial.